Immunotherapy Shows Potential to Treat Deadly Thyroid Cancer - News Center
Combination immunotherapy shows promise in treating anaplastic thyroid carcinoma, a rare and aggressive form of thyroid cancer, with a response rate of 30%.
What are cancer vaccines and have scientists finally found a cure?
Cancer vaccines are personalized treatments designed to help the patient's immune system recognize and eliminate cancer cells.
World-first lung cancer vaccine trials launched across seven countries
The world's first mRNA lung cancer vaccine, BNT116, shows promise in treating non-small cell lung cancer and improving survival rates.
Immunotherapy Shows Potential to Treat Deadly Thyroid Cancer - News Center
Combination immunotherapy shows promise in treating anaplastic thyroid carcinoma, a rare and aggressive form of thyroid cancer, with a response rate of 30%.
What are cancer vaccines and have scientists finally found a cure?
Cancer vaccines are personalized treatments designed to help the patient's immune system recognize and eliminate cancer cells.
World-first lung cancer vaccine trials launched across seven countries
The world's first mRNA lung cancer vaccine, BNT116, shows promise in treating non-small cell lung cancer and improving survival rates.
Neuralink Competitor Restores Vision in Blind Patients With Eye Implant
Science Corporation has developed a groundbreaking retinal implant, Prima, that restores eyesight in legally blind patients, marking a significant advance in biomedical technology.
InxMed Presents Data regarding Potential Novel Way to Improve Therapeutic Window of ADC by Ifebemtinib and FIC ADC at 15th Annual World ADC
InxMed is developing ifebemtinib to enhance ADC effectiveness by reducing fibrotic barriers in tumors.
# Penny Stocks to Buy With $100
Penny stocks can be risky but offer significant potential returns if chosen wisely.
Neuralink Competitor Restores Vision in Blind Patients With Eye Implant
Science Corporation has developed a groundbreaking retinal implant, Prima, that restores eyesight in legally blind patients, marking a significant advance in biomedical technology.
InxMed Presents Data regarding Potential Novel Way to Improve Therapeutic Window of ADC by Ifebemtinib and FIC ADC at 15th Annual World ADC
InxMed is developing ifebemtinib to enhance ADC effectiveness by reducing fibrotic barriers in tumors.
# Penny Stocks to Buy With $100
Penny stocks can be risky but offer significant potential returns if chosen wisely.
Trial results for new lung cancer drug are off the charts', say doctors
A new drug, lorlatinib, has shown unprecedented success in stopping lung cancer progression, leading to a longer survival rate compared to standard treatment.
Graphene-chip implant in UK trial could transform brain tumour surgery
The new graphene brain chip could revolutionize brain tumor surgery by accurately distinguishing cancerous from healthy cells.
Trial results for new lung cancer drug are off the charts', say doctors
A new drug, lorlatinib, has shown unprecedented success in stopping lung cancer progression, leading to a longer survival rate compared to standard treatment.
Graphene-chip implant in UK trial could transform brain tumour surgery
The new graphene brain chip could revolutionize brain tumor surgery by accurately distinguishing cancerous from healthy cells.
New Psychiatric Technique Asks Schizophrenics to Engage in Dialogue With the Voices in Their Heads
Avatar therapy uses digital avatars to help people confront and manage auditory hallucinations effectively.
People with depression could administer brain stimulation at home, trial shows
Self-administered electrical brain stimulation may effectively alleviate major depression symptoms at home, particularly for those unresponsive to traditional therapies.
Studying the Mental Health Impact of Weight Loss Drugs - News Center
Semaglutide is safe for those without significant mental health disorders, based on a recent clinical trial.
Day One: Placebo Workshop: Translational Research Domains and Key Questions
The NIMH Placebo Workshop aims to investigate the significance of placebo effects in mental health research.
Understanding depression: The role of research in unravelling its complexities - London Business News | Londonlovesbusiness.com
Depression is complex and prevalent, necessitating ongoing research for effective treatment options.
New Psychiatric Technique Asks Schizophrenics to Engage in Dialogue With the Voices in Their Heads
Avatar therapy uses digital avatars to help people confront and manage auditory hallucinations effectively.
People with depression could administer brain stimulation at home, trial shows
Self-administered electrical brain stimulation may effectively alleviate major depression symptoms at home, particularly for those unresponsive to traditional therapies.
Studying the Mental Health Impact of Weight Loss Drugs - News Center
Semaglutide is safe for those without significant mental health disorders, based on a recent clinical trial.
Day One: Placebo Workshop: Translational Research Domains and Key Questions
The NIMH Placebo Workshop aims to investigate the significance of placebo effects in mental health research.
Understanding depression: The role of research in unravelling its complexities - London Business News | Londonlovesbusiness.com
Depression is complex and prevalent, necessitating ongoing research for effective treatment options.
Thrombectomy Does Not Improve Outcomes for Patients with Large Strokes - News Center
Endovascular thrombectomy did not significantly improve outcomes after 90 days for patients with large core strokes compared to standard care.
Leading Prostate Cancer Research for More than 20 Years - News Center
Prostate cancer is the leading cancer type in men, emphasizing the significance of specialized research programs for improved outcomes and patient care.
Thrombectomy Does Not Improve Outcomes for Patients with Large Strokes - News Center
Endovascular thrombectomy did not significantly improve outcomes after 90 days for patients with large core strokes compared to standard care.
Leading Prostate Cancer Research for More than 20 Years - News Center
Prostate cancer is the leading cancer type in men, emphasizing the significance of specialized research programs for improved outcomes and patient care.
Why do obesity drugs seem to treat so many other ailments?
GLP-1 drugs may reduce cravings for alcohol and other addictions while also addressing obesity and other health conditions.
New Study Finds Wegovy Reduces COVID Death Risk By 33 Percent
Novo Nordisk's Wegovy reduces COVID-19 mortality risk by one-third in obese patients, indicating potential health benefits beyond obesity treatment.
Novo Nordisk's new weight-loss pill Amycretin beats Wegovy in early trial
Novo Nordisk's Amycretin shows promise for rapid weight loss, potentially surpassing current leading drugs like Wegovy and Ozempic.
Novo Nordisk's new weight-loss pill Amycretin beats Wegovy in early trial
Novo Nordisk's Amycretin shows greater weight loss potential than Wegovy in early trials, marking a significant development in obesity treatment.
Pumping the unemployed with weight-loss drugs echoes Victorian attitudes to the poor | Kenan Malik
The UK is exploring pilot schemes to improve obesity care with pharmaceutical companies, focusing on economic outcomes rather than individual health benefits.
Five Top Obesity Stocks to Buy and Hold Long Term
Viking Therapeutics' VK2735 obesity treatment stock presents a promising investment opportunity ahead of its Phase 3 trials due to recent positive data.
Why do obesity drugs seem to treat so many other ailments?
GLP-1 drugs may reduce cravings for alcohol and other addictions while also addressing obesity and other health conditions.
New Study Finds Wegovy Reduces COVID Death Risk By 33 Percent
Novo Nordisk's Wegovy reduces COVID-19 mortality risk by one-third in obese patients, indicating potential health benefits beyond obesity treatment.
Novo Nordisk's new weight-loss pill Amycretin beats Wegovy in early trial
Novo Nordisk's Amycretin shows promise for rapid weight loss, potentially surpassing current leading drugs like Wegovy and Ozempic.
Novo Nordisk's new weight-loss pill Amycretin beats Wegovy in early trial
Novo Nordisk's Amycretin shows greater weight loss potential than Wegovy in early trials, marking a significant development in obesity treatment.
Pumping the unemployed with weight-loss drugs echoes Victorian attitudes to the poor | Kenan Malik
The UK is exploring pilot schemes to improve obesity care with pharmaceutical companies, focusing on economic outcomes rather than individual health benefits.
Five Top Obesity Stocks to Buy and Hold Long Term
Viking Therapeutics' VK2735 obesity treatment stock presents a promising investment opportunity ahead of its Phase 3 trials due to recent positive data.
Blood tests could soon predict your risk of Alzheimer's
Blood test for Alzheimer's risk could soon be as simple as testing cholesterol levels.
Can flashing lights stall Alzheimer's? What the science shows
Immersive audiovisual experiences may help combat Alzheimer's symptoms, showing promise in stabilizing cognitive decline in patients.
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The regulatory approval path for simufilam is fraught with controversy and allegations of research misconduct.
Francisco Lopera obituary: neurologist who traced genetic origin of early-onset Alzheimer's
Francisco Lopera's family-centered approach transformed Alzheimer's research, enhancing understanding of the disease's genetics and fostering trust in clinical settings.
Neglecting sex and gender in research is a public-health risk
The consideration of sex and gender in clinical trials and medical practice is crucial for more personalized and effective treatments.
Blood tests could soon predict your risk of Alzheimer's
Blood test for Alzheimer's risk could soon be as simple as testing cholesterol levels.
Can flashing lights stall Alzheimer's? What the science shows
Immersive audiovisual experiences may help combat Alzheimer's symptoms, showing promise in stabilizing cognitive decline in patients.
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The regulatory approval path for simufilam is fraught with controversy and allegations of research misconduct.
Francisco Lopera obituary: neurologist who traced genetic origin of early-onset Alzheimer's
Francisco Lopera's family-centered approach transformed Alzheimer's research, enhancing understanding of the disease's genetics and fostering trust in clinical settings.
Neglecting sex and gender in research is a public-health risk
The consideration of sex and gender in clinical trials and medical practice is crucial for more personalized and effective treatments.
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
Lenacapavir, a twice-yearly injectable, is shown to be more effective than Truvada in preventing HIV in recent clinical trials.
This preventive drug could be a 'game changer' in ending the HIV epidemic
Lenacapavir shows potential to significantly reduce new HIV infections, fostering optimism towards the goal of ending the epidemic by 2030.
Trial shows that shot taken twice a year very effective at preventing HIV in women - LGBTQ Nation
Lenacapavir injections taken twice yearly show 100% efficacy in preventing HIV infections in women and girls.
More good news about the twice-yearly PrEP injection - Queerty
Lenacapavir, a new injectable PrEP, shows promising effectiveness in trials, particularly for populations previously underserved by existing medications.
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
Lenacapavir, a twice-yearly injectable, is shown to be more effective than Truvada in preventing HIV in recent clinical trials.
This preventive drug could be a 'game changer' in ending the HIV epidemic
Lenacapavir shows potential to significantly reduce new HIV infections, fostering optimism towards the goal of ending the epidemic by 2030.
Trial shows that shot taken twice a year very effective at preventing HIV in women - LGBTQ Nation
Lenacapavir injections taken twice yearly show 100% efficacy in preventing HIV infections in women and girls.
More good news about the twice-yearly PrEP injection - Queerty
Lenacapavir, a new injectable PrEP, shows promising effectiveness in trials, particularly for populations previously underserved by existing medications.
Stem Cell Treatment Worked on One Patient's Type 1 Diabetes
Stem cell therapy shows promising results in reversing type 1 diabetes, leading to sustained insulin independence and improved glycemic control.
Study Suggests Fasting's Benefits Might Start When It Stops
Fasting has potential health benefits, particularly related to fat metabolism and intestinal repair, yet may also carry risks like increasing precancerous cells.
Stem Cell Treatment Worked on One Patient's Type 1 Diabetes
Stem cell therapy shows promising results in reversing type 1 diabetes, leading to sustained insulin independence and improved glycemic control.
Study Suggests Fasting's Benefits Might Start When It Stops
Fasting has potential health benefits, particularly related to fat metabolism and intestinal repair, yet may also carry risks like increasing precancerous cells.
BioAge Labs IPO: Stock price will be closely watched today as the obesity drug developer debuts on the Nasdaq
BioAge Labs is entering the public market with its obesity drug Azelaprag in clinical trials, aiming for significant growth and competition in the weight loss sector.
Data integrity concerns flagged in 130 women's health papers - all by one co-author
Concerns about data integrity have been raised in 130 studies by a biomedical researcher, influencing clinical practice rooted in questionable data.
How precision medicine is tackling stubborn cancers in 2024
Cancer cases and deaths are projected to increase significantly by 2040 despite advancements in treatment.
Precision medicine offers personalized cancer treatment by targeting specific mutations, maximizing effectiveness, and minimizing side effects.
Treatment Strategies for CNS Complications in People with HIV
Identify modifiable targets and mechanisms to improve CNS-related outcomes in individuals with HIV, enhancing their quality of life and functional capacity.
How precision medicine is tackling stubborn cancers in 2024
Cancer cases and deaths are projected to increase significantly by 2040 despite advancements in treatment.
Precision medicine offers personalized cancer treatment by targeting specific mutations, maximizing effectiveness, and minimizing side effects.
Treatment Strategies for CNS Complications in People with HIV
Identify modifiable targets and mechanisms to improve CNS-related outcomes in individuals with HIV, enhancing their quality of life and functional capacity.
FDA's review of MDMA for PTSD highlights study bias and safety concerns
MDMA for PTSD therapy efficacy is under FDA review due to flawed trials and safety concerns, marking a potential shift in federal policy.
FDA rejects ecstasy as a therapy: what's next for psychedelics?
FDA rejected MDMA for psychiatric treatment, prompting questions about future psychedelic therapies.
No, the FDA Didn't Reject MDMA Therapy Because of Big Pharma-It Was Because of Shoddy Science
FDA's rejection of MDMA-assisted therapy signals a need for rigorous trial standards in psychedelic research, despite initial promising results.
More bad news for psychedelic drug company: FDA expands probe after rejection
The FDA's rejection of Lykos' MDMA therapy has prompted a deeper investigation into clinical trial misconduct and serious allegations.
F.D.A. Declines to Approve MDMA Therapy, Seeking More Study
FDA declined to approve MDMA-assisted therapy for PTSD due to insufficient data, requesting additional clinical trials.
Opinion | How Psychedelic Research Got High on Its Own Supply
Lykos Therapeutics faced a significant setback with the F.D.A.'s rejection of their MDMA PTSD treatment application, raising concerns about trial integrity.
FDA's review of MDMA for PTSD highlights study bias and safety concerns
MDMA for PTSD therapy efficacy is under FDA review due to flawed trials and safety concerns, marking a potential shift in federal policy.
FDA rejects ecstasy as a therapy: what's next for psychedelics?
FDA rejected MDMA for psychiatric treatment, prompting questions about future psychedelic therapies.
No, the FDA Didn't Reject MDMA Therapy Because of Big Pharma-It Was Because of Shoddy Science
FDA's rejection of MDMA-assisted therapy signals a need for rigorous trial standards in psychedelic research, despite initial promising results.
More bad news for psychedelic drug company: FDA expands probe after rejection
The FDA's rejection of Lykos' MDMA therapy has prompted a deeper investigation into clinical trial misconduct and serious allegations.
F.D.A. Declines to Approve MDMA Therapy, Seeking More Study
FDA declined to approve MDMA-assisted therapy for PTSD due to insufficient data, requesting additional clinical trials.
Opinion | How Psychedelic Research Got High on Its Own Supply
Lykos Therapeutics faced a significant setback with the F.D.A.'s rejection of their MDMA PTSD treatment application, raising concerns about trial integrity.
Another patient will get Neuralink's brain implant
Neuralink approved for second brain implant procedure for patients with ALS, spinal cord injuries or quadriplegia.
An exciting time:' Breakthroughs coming to treat and prevent hair loss
Young people experience early hair loss due to anxiety and poor diet. FDA-approved treatments are limited, but new medications and therapies are in clinical trials.
As the FDA evaluates ecstasy treatment for PTSD, questions mount about the evidence
MDMA's potential for PTSD treatment faces uncertainty in FDA approval.
3 Trending Biotech Penny Stocks
Biotech stocks can yield high returns while benefiting patients; they're influenced by clinical trials and regulatory decisions.
Another patient will get Neuralink's brain implant
Neuralink approved for second brain implant procedure for patients with ALS, spinal cord injuries or quadriplegia.
An exciting time:' Breakthroughs coming to treat and prevent hair loss
Young people experience early hair loss due to anxiety and poor diet. FDA-approved treatments are limited, but new medications and therapies are in clinical trials.
As the FDA evaluates ecstasy treatment for PTSD, questions mount about the evidence
MDMA's potential for PTSD treatment faces uncertainty in FDA approval.
3 Trending Biotech Penny Stocks
Biotech stocks can yield high returns while benefiting patients; they're influenced by clinical trials and regulatory decisions.
MDMA for PTSD: Three studies retracted on heels of FDA rejection
The FDA rejected MDMA therapy for PTSD due to concerns about flawed clinical trials and biases in people involved, prompting retraction of supporting studies.
The Uncertain Path Forward for Psychedelic Medicine
Unblinded trials compromise reliability, raising efficacy concerns for psychedelic therapy effectiveness in clinical studies.
MDMA for PTSD: Three studies retracted on heels of FDA rejection
The FDA rejected MDMA therapy for PTSD due to concerns about flawed clinical trials and biases in people involved, prompting retraction of supporting studies.
The Uncertain Path Forward for Psychedelic Medicine
Unblinded trials compromise reliability, raising efficacy concerns for psychedelic therapy effectiveness in clinical studies.
The webinar is designed to clarify NIH's definition of a clinical trial to support global mental health research efforts.
A protein-blocking drug extended life by 25% in mice. Could it work in humans?
Inhibiting the protein interleukin-11 (IL-11) in mice extended lifespan by up to 25% and improved health indicators, providing a potential pathway for longevity in humans.
Germany's Protembis secures 20M from EIB - Silicon Canals
EIB grants €20M to Protembis for ProtEmbo system development.
New HIV preventive strategy sparks excitement and protests at AIDS conference
The new HIV prevention treatment, lenacapavir injection, showed 100% efficacy in early trials, offering an alternative to daily pills like Truvada for prevention efforts.